Abstract
Atopic dermatitis (AD) patients suffer from increased susceptibility to cutaneous viral infections and diminished epidermal barrier function, including defects in TJ integrity and reduced claudin-1 (CLDN1) expression. To understand the role of CLDN1 in epidermal viral infections, we generated keratinocytes (KC) lacking CLDN1 using CRISPR/Cas9 technology. CLDN1 knockout (CLDN1KO) KC were evaluated for barrier function, differentiation, and susceptibility to vaccinia virus (VV), the causative agent of the life-threatening, AD-related complication, eczema vaccinatum.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
